VALSARTAN RATIOPHARM 160 mg tabletti, kalvopäällysteinen فنلندا - الفنلندية - Fimea (Suomen lääkevirasto)

valsartan ratiopharm 160 mg tabletti, kalvopäällysteinen

ratiopharm gmbh - valsartanum - tabletti, kalvopäällysteinen - 160 mg - valsartaani

TADALAFIL RATIOPHARM 2.5 mg tabletti, kalvopäällysteinen فنلندا - الفنلندية - Fimea (Suomen lääkevirasto)

tadalafil ratiopharm 2.5 mg tabletti, kalvopäällysteinen

ratiopharm gmbh - tadalafilum - tabletti, kalvopäällysteinen - 2.5 mg - tadalafiili

Omeprazol ratiopharm 20 mg enterokapseli, kova فنلندا - الفنلندية - Fimea (Suomen lääkevirasto)

omeprazol ratiopharm 20 mg enterokapseli, kova

ratiopharm gmbh - omeprazole - enterokapseli, kova - 20 mg - omepratsoli

Omeprazol ratiopharm 10 mg enterokapseli, kova فنلندا - الفنلندية - Fimea (Suomen lääkevirasto)

omeprazol ratiopharm 10 mg enterokapseli, kova

ratiopharm gmbh - omeprazole - enterokapseli, kova - 10 mg - omepratsoli

Omeprazol ratiopharm 40 mg enterokapseli, kova فنلندا - الفنلندية - Fimea (Suomen lääkevirasto)

omeprazol ratiopharm 40 mg enterokapseli, kova

ratiopharm gmbh - omeprazole - enterokapseli, kova - 40 mg - omepratsoli

Dasatinib Accordpharma الاتحاد الأوروبي - الفنلندية - EMA (European Medicines Agency)

dasatinib accordpharma

accord healthcare s.l.u. - dasatinibin - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiset aineet - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.

Alfuzosin Hydrochlorid Ratiopharm 10 mg depottabletti فنلندا - الفنلندية - Fimea (Suomen lääkevirasto)

alfuzosin hydrochlorid ratiopharm 10 mg depottabletti

ratiopharm gmbh - alfuzosin hydrochloride - depottabletti - 10 mg - alfutsosiini

Letrozol Ratiopharm 2.5 mg tabletti, kalvopäällysteinen فنلندا - الفنلندية - Fimea (Suomen lääkevirasto)

letrozol ratiopharm 2.5 mg tabletti, kalvopäällysteinen

ratiopharm gmbh - letrozole - tabletti, kalvopäällysteinen - 2.5 mg - letrotsoli

Imatinib ratiopharm 100 mg tabletti, kalvopäällysteinen فنلندا - الفنلندية - Fimea (Suomen lääkevirasto)

imatinib ratiopharm 100 mg tabletti, kalvopäällysteinen

ratiopharm gmbh - imatinib mesylate - tabletti, kalvopäällysteinen - 100 mg - imatinibi

Imatinib ratiopharm 400 mg tabletti, kalvopäällysteinen فنلندا - الفنلندية - Fimea (Suomen lääkevirasto)

imatinib ratiopharm 400 mg tabletti, kalvopäällysteinen

ratiopharm gmbh - imatinib mesylate - tabletti, kalvopäällysteinen - 400 mg - imatinibi